The results show that CYP4X1 expression was significantly higher in colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ) compared to normal tissues, as further confirmed through UALCAN analysis. This evidence concerns the gene CYP4X1 and rectum adenocarcinoma.